当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Emilio Gutiérrez, Carlos Libisch and Olaia Carrera
A dispassionate view of psychotherapy, leaving aside allegiances to particular schools, reveals it is extremely uncommon to find clear differences in efficacy between diverse treatment approaches (Luborsky et al., 2002). Even worse, when active treatments are compared to structurally equivalent placebos, only negligible effects are obtained in comparison to former treatments (Baskin, Tierney, Minami & Wampold, 2003). A plausible explanation for the apparent similarity in efficacy of different treatments is the existence of underlying common factors shared by all treatments which is ultimately responsible for the purported equivalence attained by different therapeutic approaches (Frank & Frank, 1993). This shared equivalence has been recently reinforced by the literature on placebo, and particularly research using neuroimaging techniques showing how patients’ expectancies interact with the clinical setting stimulating the rewarding brain circuitry.